Colorado ketamine review reveals potential bias in use

GLENDALE, Colo. (KDVR) – More than a year after the state health department promised to conduct an “immediate and thorough” review of the program allowing healthcare workers to Sedating patients with ketamine outside the hospital established, Colorado Department of Public Health and Environment Ketamine investigation review board found that some people may have received the medication unnecessarily.

“The panel agreed that ketamine is a safe drug if used correctly and under close supervision by trained and qualified medical personnel. However, certain side effects appear to have arisen mainly from the use of ketamine and other sedatives by people who may not have a medical need for these drugs and who could have been managed with a less assertive alternative method,” according to an executive summary of the review released to the Problem Solver. “Moreover, other social and systemic factors at play may have allowed chemical restraints to be disproportionately applied to marginalized populations and communities of color in the United States. Colorado and across the country.”

The following people have served on the board: Dr. Gene Eby, emergency medicine physician Dr. Janetta Iwanicki, medical toxicologist and emergency medicine physician, Dr. Luis A. Verduzco, physician anesthesiologist, Dr. Lesley Brooks, a family pharmacy and addiction medicine physician, Dr. Christopher T. Stephens, an anesthesiologist and former paramedic, Dr. Scott Bourn, an RN, MSN, PhD Doctor of Health and Behavioral Sciences, and Dr. Jamira T. Jones, MPH, an emergency medicine physician.

The panel made several recommendations to improve the way the drug is used, but the state department of health will continue to suspend its use for now.

“The panel recommends that euphoria should no longer be used as a guarantee of exemption from ketamine use. In making this recommendation, the panel acknowledges that in the pre-hospital setting, a patient’s agitation and disorientation may pose a direct threat to patient safety as well as to patient safety. of the public and first responders,” the executive summary said.

The panel also made recommendations on dosage, considering whether there is disproportionate use of the drug in communities of color, patient monitoring, and training.

The state health department first announced that it would review its waiver program in August 2020, after Problem solver discovered suspicious cases where the drug is used on patients involved in police situations.

“Patient safety and program transparency are top priorities,” said Jill Hunsaker Ryan, chief executive officer of CDPHE, in a statement. his announcement a year ago.

The use of ketamine became controversial after the death of Elijah McClain. In 2019, he was confronted by three Aurora officers, who used a carotid retainer to subdue him, and paramedics who injected him with ketamine before he went into cardiac arrest and subsequently died. . His family recently settled a civil lawsuit with the City of Aurora for $15 million.

The panel of experts that worked to review ketamine also drew on data and information from a variety of health professionals around the country, including Dr. Brent Myers, a ketamine researcher who is certified three pounds in emergencymedicine, EMS, and clinical informatics.

https://kdvr.com/news/problem-solvers/ketamine-review-chemical-restraints-may-have-been-disproportionately-applied-to-communities-of-color/ Colorado ketamine review reveals potential bias in use

Emma Bowman

USTimeToday is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@ustimetoday.com. The content will be deleted within 24 hours.

Related Articles

Back to top button